The MarketWatch News Department was not involved in the creation of this content.
Sep 29, 2020 (Market Insight Reports) —
The Regenerative Medicine Market Perspective, Comprehensive Analysis along with Major Segments and Forecast, 2020-2026. The Regenerative Medicine market report is a valuable source of data for business strategists. It provides the industry overview with market growth analysis with a historical & futuristic perspective for the following parameters; cost, revenue, demands, and supply data (as applicable). The report explores the current outlook in global and key regions from the perspective of players, countries, product types, and end industries. This Regenerative Medicine Market study provides comprehensive data that enhances the understanding, scope, and application of this report.
Top Companies in the Global Regenerative Medicine Market
DePuy Synthes, Osiris Therapeutics, Medtronic plc (NYSE: MDT), Stryker Corporation (NYSE: SYK), Acelity, Zimmer Biomet Holdings, Inc. (NYSE: ZBH), UniQure, MiMedx Group, Cellular Dynamics International, Organogenesis, Vericel Corporation, Mesoblast, Guanhao Biotech, Vcanbio, Cytori, Golden Meditech, Bellicum Pharmaceuticals, Celgene, Gamida Cell, Stemcell Technologies, among others.
According to this study, over the next five years, the Regenerative Medicine market will register a 24.3% CAGR in terms of revenue, the global market size will reach $ 19360 million by 2025, from $ 8118.3 million in 2019.
Regenerative medicine is a branch of translational research in tissue engineering and molecular biology which deals with the “process of replacing, engineering or regenerating human cells, tissues or organs to restore or establish normal function”. It is through the use of innovative medical means rebuilding diseased or damaged tissue or to support diseased or damaged tissue regeneration. The methods used include cell therapy, tissue engineering, chemically induced and therapeutic cloning, etc. Any combination of these technologies may be used to harness or stimulate the body’s innate healing ability to treat a wide range of ailments, including musculoskeletal-related conditions, cardio- and peripheral vascular diseases, neurological disorders, stroke, non-healing wounds, and ocular diseases.
Get a Sample PDF Copy of the Latest Research on Regenerative Medicine Market 2020 Before the purchase
According to the estimation of the World Health Organization, there is an increasing prevalence of diabetes among adults over the age of 18 years, which has increased to 8.5% in 2014 compared to 4.5% in 1980 across the globe. As per the estimation of the Arthritis Foundation, the number of people expected to be diagnosed from arthritis will be more than 78 million, by 2040.
The 21st Century Cures Act, approved in December 2016, created room for the establishment of the Regenerative Medicine Innovation Project (RMIP). NIH (National Institute of Health) is leading the RMIP in coordination with the FDA. The 21st Century Cures Act approved $30 million in federal awards over four years (2020-2020) for the RMIP, thus accelerating the arena by aiding clinical research on mature stem cells while endorsing the uppermost morals for scientific research and patient safety.
Currently, some companies in the world can provide regenerative medicine services, mainly concentrating in the USA. The main market